Mamotest is a collaborative platform that leverages AI to provide early breast cancer diagnosis and patient support. Through telediagnosis and 100% patient traceability, Mamotest offers a data-driven end-to-end solution for defeating breast cancer. The platform collects medical, clinical, psychological, and socio-economic data, enabling global business and policy decision-makers to access vital information and potentially save thousands of women's lives. Mamotest's digital telemammography network offers services such as 3D mammography, breast ultrasound, and stereotactic biopsy. Founded in 2011 and based in Corrientes, Argentina, Mamotest is dedicated to delivering high-quality imaging diagnosis and comprehensive patient care.